Previous studies in our laboratory underlined the effect of compounds derived from chloroquine CQ and amodiaquine AQ, two antimalarial compounds with lysosomotropic activities that are able to modulate the amyloid and Tau pathologies, both of which are the two major pathophysiological processes of AD. Here, MAPT is linked to Alzheimer disease.